Effect of anti-seizure drugs on serum S100B in patients with focal seizure: a randomized controlled trial

ConclusionSerum S100B increases in the patients with focal seizure and therapy with carbamazepine can decrease serum S100B level significantly over oxcarbazepine. Serum S100B can be used as a prognostic biomarker in a focal seizure.

http://link.springer.com/10.1007/s00415-018-9026-1

Source: Journal of Neurology - September 1, 2018 Category: Neurology Source Type: research